RxDoctor Payments Data

Christine Darwin

Family · Montgomery, ALNPI 1235552894

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.7% of the total across 280 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 54 manufacturers, the largest accounting for just 9.1% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,513in general payments, 2019–2025

Across 280 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$503
  • Regeneron Healthcare Solutions, Inc.$488
  • Merck$435
  • Incyte Corporation$404
  • Novartis$395
  • Exelixis Inc.$338
  • plus $3K from 48 others

What the payments were for

  • Food & beverage$5,38898%
  • Education$1252%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,513 in reported general payments places this provider in the 90th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama →

Medicare billing

Part B allowed, 2024
$23,882
Medicare patients
180
Services billed
323

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Warfarin Sodium55$323
Fluconazole37$226
Ondansetron OdtOndansetron12$176
Potassium Chloride18$151
Ciprofloxacin Hcl13$115
Cephalexin11$75
Prednisone12$42
Levofloxacin19$41
JantovenWarfarin Sodium15$34

Paid to pharmacies, not to this prescriber.

Other family in Montgomery

See the full list for Alabama →

Where these figures come from

Is this you, or does something look wrong? →